Condition: Type 1 Diabetes · Chronic Inflammation · Insulin Sensitivity · Sponsor: Asger Lund, MD
The aim for this clinical trial is to evaluate if colchicine in addition to standard of care improves insulin sensitivity in individuals with type 1 diabetes, systemic low-grade inflammaiton and reduced insulin sensitivity. The insulin sensitivity will be evaluated by a hyperinsulinemic, euglycemic clamp.
This description comes directly from the study's public registry record.
Askee N. Høck, MD · +4561275585 · aske.nicolai.hoeck@regionh.dk
Always discuss trial participation with your own doctor first.
| Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Capital Region 2900 | Gentofte Municipality, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07247734